Priovant Therapeutics, Inc.
6 clinical trials · Sponsor
◉ Watch Priovant Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris (NCT07532603) | Priovant Therapeutics, Inc. | 2026-03-19 |
| A Phase 2/3 Study of Brepocitinib in Adults With Cutaneous Sarcoidosis (NCT06978725) | Priovant Therapeutics, Inc. | 2025-04-09 |
| A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis (NCT06431373) | Priovant Therapeutics, Inc. | 2024-09-11 |
| A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant Dermatomyositis (NCT06433999) | Priovant Therapeutics, Inc. | 2024-08-28 |
| A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis (NCT05523765) | Priovant Therapeutics, Inc. | 2022-11-14 |
| A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis (NCT05437263) | Priovant Therapeutics, Inc. | 2022-10-31 |
Track Priovant Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.